Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Fagin

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroidJames A Fagin
Transactions of the American Clinical and Climatological Association|March 25, 2006
Genetics of papillary thyroid cancer initiation: implications for therapyJames A Fagin
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Challenging dogma in thyroid cancer molecular genetics--role of RET/PTC and BRAF in tumor initiationJames A Fagin
Endocrinology|May 22, 2002
Perspective: lessons learned from molecular genetic studies of thyroid cancer--insights into pathogenesis and tumor-specific therapeutic targetsJames A Fagin
Transactions of the American Clinical and Climatological Association|June 6, 2008
The Jeremiah Metzger Lecture: intelligent design of cancer therapy: trials and tribulationsJames A Fagin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2022
Age of Onset of Receptor Tyrosine Kinase Fusions Drives Distinct Biologic Outcomes in Thyroid CancerJames A Fagin
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Significance of BRAF mutations in papillary thyroid carcinoma: prognostic and therapeutic implicationsLionel Groussin, James A Fagin
Nature Reviews. Endocrinology|April 1, 2015
Therapy: Lenvatinib and radioiodine-refractory thyroid cancersLara Dunn, James A Fagin
Best Practice & Research. Clinical Endocrinology & Metabolism|December 2, 2008
Molecular pathology of thyroid cancer: diagnostic and clinical implicationsJames A Fagin, Nicholas Mitsiades
Nature Reviews. Endocrinology|December 11, 2019
Therapeutic breakthroughs for metastatic thyroid cancerVera Tiedje, James A Fagin
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroidJames A Fagin
Transactions of the American Clinical and Climatological Association|March 25, 2006
Genetics of papillary thyroid cancer initiation: implications for therapyJames A Fagin
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Challenging dogma in thyroid cancer molecular genetics--role of RET/PTC and BRAF in tumor initiationJames A Fagin
Endocrinology|May 22, 2002
Perspective: lessons learned from molecular genetic studies of thyroid cancer--insights into pathogenesis and tumor-specific therapeutic targetsJames A Fagin
Transactions of the American Clinical and Climatological Association|June 6, 2008
The Jeremiah Metzger Lecture: intelligent design of cancer therapy: trials and tribulationsJames A Fagin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2022
Age of Onset of Receptor Tyrosine Kinase Fusions Drives Distinct Biologic Outcomes in Thyroid CancerJames A Fagin
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Significance of BRAF mutations in papillary thyroid carcinoma: prognostic and therapeutic implicationsLionel Groussin, James A Fagin
Nature Reviews. Endocrinology|April 1, 2015
Therapy: Lenvatinib and radioiodine-refractory thyroid cancersLara Dunn, James A Fagin
Best Practice & Research. Clinical Endocrinology & Metabolism|December 2, 2008
Molecular pathology of thyroid cancer: diagnostic and clinical implicationsJames A Fagin, Nicholas Mitsiades
Nature Reviews. Endocrinology|December 11, 2019
Therapeutic breakthroughs for metastatic thyroid cancerVera Tiedje, James A Fagin
Pageof 16